Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Effect of CagriSema on continuous glucose monitoring in people with inadequately controlled type 2 diabetes: REIMAGINE 2

Authors :

Julia K. Mader1; John B. Buse2; Helene H. Hansen Duus3; Therese Wilbek Fabricius3; Chantal Mathieu4; Alex Videmark3; Harpreet S. Bajaj5

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download the poster (.pdf)
Keywords
Diabetes
Congress short oral presentation
Amylin
CagriSema
PHASE 3 (RCT)